Skip to main content

Table 2 Tumor staging information of the 307 patients with hepatocellular carcinoma

From: Optimal staging system for predicting the prognosis of patients with hepatocellular carcinoma in China: a retrospective study

Staging system

Patients (%)

CLIP

 

 0

95 (30.9)

 1

86 (28.0)

 2

42 (13.7)

 3

53 (17.3)

 4

21 (6.8)

 5

8 (2.6)

 6

2 (0.7)

BCLC

 

 0

10 (3.3)

 A

45 (14.7)

 B

32 (10.4)

 C

196 (63.8)

 D

24 (7.8)

TNMa

 

 I

133 (43.3)

 II

41 (13.4)

 IIIA

15 (4.9)

 IIIB

37 (12.0)

 IIIC

11 (3.6)

 IVA

41 (13.4)

 IVB

29 (9.4)

CS

 

 Ia

49 (16.0)

 Ib

42 (13.7)

 IIa

51 (16.6)

 IIb

63 (20.5)

 IIIa

90 (29.3)

 IIIb

12 (3.9)

  1. aSeventh edition